Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Chunguang Wang is active.

Publication


Featured researches published by Chunguang Wang.


Archive | 2002

2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer

Dhanapalan Nagarathnam; Chunguang Wang; Yuanwei Chen; Lin Yi; Jianqing Chen; Olaf Weber; Stephen Boyer; Roger B. Clark; Barton Phillips; Jennifer Burke; Gaetan Ladouceur; Cheng Bi; Michael J. Burke; James H. Cook; Sharad Verma; Jianmei Fan


Archive | 2003

Roh-kinase inhibitors

Dhanapalan Nagarathnam; Uday Khire; Davoud Asgari; Jianxing Shao; Xiao-Gao Liu; Chunguang Wang; Barry Hart; Olaf Weber; Mark Lynch; Lei Zhang; Lei Wang


Archive | 2003

2-4-(di-phenyl-amino)-pyrimidine derivatives useful for treating hyper-proliferative disorders

Jill E. Wood; Donald Bierer; Brian Bear; Catherine Brennan; Brent Chandler; Gang Chen; Yuanwei Chen; Julie Dixon; Wenlang Fu; Leatte Guernon; Donglei Liu; Andrea Mcclure; Karl Miranda; Dhanapalan Nagarathnam; Robert Sibley; Michael Robert Turner; Sharad Verma; Chunguang Wang; Lin Yi; Jin Zhao; Qingming Zhu


Archive | 2003

Pyrimidine derivatives as rho-kinase inhibitors

Dhanapalan Nagarathnam; Jacques Dumas; Holia Hatoum-Mokdad; Stephen Boyer; Chunguang Wang; Hans Pluempe; Achim Feurer; Samir Bennabi


Bioorganic & Medicinal Chemistry Letters | 2005

Substituted aminobenzimidazole pyrimidines as cyclin-dependent kinase inhibitors

Sharad Verma; Dhanapalan Nagarathnam; Jianxing Shao; Lei Zhang; Jin Zhao; Yamin Wang; Tindy Li; Eric S. Mull; Istvan Enyedy; Chunguang Wang; Qingming Zhu; Martha Altieri; Jerold Jordan; Thu Thi Anh Dang; Sanjeeva P. Reddy


Archive | 2004

Pyrimidine derivatives for treatment of hyperproliferative disorders

Julie A. Dixon; Dhanapalan Nagarathnam; Lei Zhang; Chunguang Wang; Lin Yi; Yuanwei Chen; Jianqing Chen; Brian Bear; Michael Brands; Alexander Hillisch; Donald Bierer; Ming Wang; Wenlang Fu; Martin F. Hentemann; Ann-Marie Bullion


Archive | 2003

Process for preparing quinazoline rho-kinase inhibitors and intermediates thereof

Donald Bankston; Dhanaphalan Nagarathnam; Davoud Asgari; Jianxing Shao; Xiao-Gao Liu; Uday Khire; Chunguang Wang; Barry Hart; Stephen Boyer; Olaf Weber; Mark Lynch


Archive | 2007

Substituted thieno[3,2-D]pyrimidines as Rho kinase inhibitors

Dhanapalan Nagarathnam; Uday Khire; Davoud Asgari; Jianxing Shao; Xiao-Gao Liu; Chunguang Wang; Barry Hart; Olaf Weber; Mark Lynch; Lei Zhang; Lei Wang


Archive | 2010

METHOD FOR PRODUCING QUINAZOLINE RHO-KINASE INHIBITOR AND INTERMEDIATE THEREOF

Davoud Asgari; Donald Bankston; Stephen Boyer; Barry Hart; Uday Khire; Xiao-Gao Liu; Mark Lynch; Dhanaphalan Nagarathnam; Jianxing Shao; Chunguang Wang; Olaf Weber; アスガリ,ダブード; ウェーバー,オラフ; クハイア,ウデイ; シャオ,ジャンシン; ナガラスナム,ドハナファラン; ハート,ベエアリー; バンクストン,ドナルド; ボイヤー,スティーブン; リウ,シャオーガオ; リンチ,マーク; ワン,チュングアン


Archive | 2009

***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***Pyrimidine derivatives for treatment of hyperproliferative disorders

Julie A. Dixon; Dhanapalan Nagarathnam; Lei Zhang; Chunguang Wang; Lin Yi; Yuanwei Chen; Jianqing Chen; Brian Bear; Michael Brands; Alexander Hillisch; Donald Bierer; Ming Wang; Wenlang Fu; Martin F. Hentemann; Ann-Marie Bullion; Manoj Patel

Collaboration


Dive into the Chunguang Wang's collaboration.

Researchain Logo
Decentralizing Knowledge